Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Chipscreen, Ocuphire, Outlook, Phathom, Pierre Fabre, Prokarium, Reset, Scilex, Sumitomo, Supernus, Verona.